Biogen Idec to Present at the DB Access BioFEST Conference

  Biogen Idec to Present at the DB Access BioFEST Conference

Business Wire

WESTON, Mass. -- November 26, 2012

Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the
DB Access BioFEST Conference will be webcast live on Monday, December 3, 2012
at 8:25 a.m. ET. To access the live webcast, please visit Biogen Idec’s
Investors section at An archived version of the webcast
will be available for 14 days following the presentation.

About Biogen Idec

Through cutting-edge science and medicine, Biogen Idec discovers, develops and
delivers to patients worldwide innovative therapies for the treatment of
neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in
1978, Biogen Idec is the world’s oldest independent biotechnology company.
Patients worldwide benefit from its leading multiple sclerosis therapies, and
the company generates more than $5 billion in annual revenues. For product
labeling, press releases and additional information about the company, please


Biogen Idec
Karen Jewell, 781-464-2442
Investor Relations
Press spacebar to pause and continue. Press esc to stop.